These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32376491)

  • 1. Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma.
    Sheehan WJ; Krouse RZ; Calatroni A; Gergen PJ; Gern JE; Gill MA; Gruchalla RS; Khurana Hershey GK; Kattan M; Kercsmar CM; Lamm CI; Little FF; Makhija MM; Searing DA; Zoratti E; Busse WW; Teach SJ;
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3021-3028.e2. PubMed ID: 32376491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index.
    Hoch HE; Calatroni A; West JB; Liu AH; Gergen PJ; Gruchalla RS; Khurana Hershey GK; Kercsmar CM; Kim H; Lamm CI; Makhija MM; Mitchell HE; Teach SJ; Wildfire JJ; Busse WW; Szefler SJ
    J Allergy Clin Immunol; 2017 Oct; 140(4):1130-1137.e5. PubMed ID: 28238748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.
    Teach SJ; Gill MA; Togias A; Sorkness CA; Arbes SJ; Calatroni A; Wildfire JJ; Gergen PJ; Cohen RT; Pongracic JA; Kercsmar CM; Khurana Hershey GK; Gruchalla RS; Liu AH; Zoratti EM; Kattan M; Grindle KA; Gern JE; Busse WW; Szefler SJ
    J Allergy Clin Immunol; 2015 Dec; 136(6):1476-1485. PubMed ID: 26518090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal risk factors for asthma exacerbations among inner-city children.
    Teach SJ; Gergen PJ; Szefler SJ; Mitchell HE; Calatroni A; Wildfire J; Bloomberg GR; Kercsmar CM; Liu AH; Makhija MM; Matsui E; Morgan W; O'Connor G; Busse WW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1465-73.e5. PubMed ID: 25794658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
    Szefler SJ; Casale TB; Haselkorn T; Yoo B; Ortiz B; Kattan M; Busse WW
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2673-2680.e3. PubMed ID: 32298853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.
    Tajiri T; Matsumoto H; Gon Y; Ito R; Hashimoto S; Izuhara K; Suzukawa M; Ohta K; Ono J; Ohta S; Ito I; Oguma T; Inoue H; Iwata T; Kanemitsu Y; Nagasaki T; Niimi A; Mishima M
    Allergy; 2016 Oct; 71(10):1472-9. PubMed ID: 27113353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.
    Massanari M; Holgate ST; Busse WW; Jimenez P; Kianifard F; Zeldin R
    Respir Med; 2010 Feb; 104(2):188-96. PubMed ID: 19846286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IgE for chronic asthma in adults and children.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003559. PubMed ID: 16625585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.
    Esquivel A; Busse WW; Calatroni A; Togias AG; Grindle KG; Bochkov YA; Gruchalla RS; Kattan M; Kercsmar CM; Khurana Hershey G; Kim H; Lebeau P; Liu AH; Szefler SJ; Teach SJ; West JB; Wildfire J; Pongracic JA; Gern JE
    Am J Respir Crit Care Med; 2017 Oct; 196(8):985-992. PubMed ID: 28608756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
    Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
    Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized multicenter study evaluating Xolair persistence of response after long-term therapy.
    Ledford D; Busse W; Trzaskoma B; Omachi TA; Rosén K; Chipps BE; Luskin AT; Solari PG
    J Allergy Clin Immunol; 2017 Jul; 140(1):162-169.e2. PubMed ID: 27826098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IgE for chronic asthma in adults and children.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
    J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
    Busse WW; Morgan WJ; Gergen PJ; Mitchell HE; Gern JE; Liu AH; Gruchalla RS; Kattan M; Teach SJ; Pongracic JA; Chmiel JF; Steinbach SF; Calatroni A; Togias A; Thompson KM; Szefler SJ; Sorkness CA
    N Engl J Med; 2011 Mar; 364(11):1005-15. PubMed ID: 21410369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
    Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
    Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E
    Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgE for chronic asthma.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003559. PubMed ID: 12917972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.
    Burch J; Griffin S; McKenna C; Walker S; Paton J; Wright K; Woolacott N
    Pharmacoeconomics; 2012 Nov; 30(11):991-1004. PubMed ID: 22950547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for autumn exacerbations of asthma in children.
    Pike KC; Akhbari M; Kneale D; Harris KM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012393. PubMed ID: 29518252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.